Abstract submission is NOW OPEN through Jan. 31, 2025! Send us your research for possible presentation at the 28th Annual Meeting!
The ASGCT Board of Directors and the Society's officers have full responsibility for the management, direction and control of the business, policies and affairs of ASGCT, subject only to limitations set forth in the Society's Articles of Incorporation and Bylaws. Learn more about the Board and Officers below.
Paula Cannon, PhD, President
Terence R. Flotte, MD, President-Elect (2024-2025)
Matthew H. Porteus, MD, PhD, Vice President (2024-2027)
Isabelle Riviere, PhD, Secretary
Federico Mingozzi, PhD, Treasurer
Aravind Asokan, PhD
Daniel E. Bauer, MD, PhD
Claire Booth, MBSS, PhD
Lindsey George, MD
Kimberly Goodspeed, MD, Clinical & Translational Council Chair
Punam Malik, MD, Science + Education Council Chair
Kah-Whye Peng, PhD
Miguel Sena-Esteves, PhD
Jennifer Wellman, MS, Membership Council Chair
Roland W. Herzog, PhD, Ex-Officio
Jeffrey Chamberlain, PhD, Immediate Past President
Read the full Society Bylaws, which were amended and restated in May 2017.
November 19-20, 2024 | Chicago, IL
© 2000-2024 All rights reserved. American Society of Gene & Cell Therapy.
Kentico CMS Development by Reason One | Powered by Kentico